《风湿症杂志》.2005年.第1期
......
- Evaluation of clinically relevant changes in patient reported outcomes in knee and hip osteoarthritis: the minimal clinically important impr
- Defining hip pain for population studies
- Contribution of polymorphisms in the apolipoprotein AI-CIII-AIV cluster to hyperlipidaemia in patients with gout
- Chondroprotective activity of N-acetylglucosamine in rabbits with experimental osteoarthritis
- Case number 32: Thiemann’s disease
- Capability for daily activities in old people with rheumatoid arthritis: a population based study
- Patient centred outcomes in osteoarthritis
- Pain and joint mobility explain individual subdimensions of the health assessment questionnaire(HAQ) disability index in patients with rheu
- Low density of sympathetic nerve fibres and increased density of brain derived neurotrophic factor positive cells in RA synovium
- Is rheumatoid arthritis disappearing?
- Incidence and prevalence of complaints of the neck and upper extremity in general practice
- First line treatment of knee osteoarthritis in outpatients in France: adherence to the EULAR 2000 recommendations and factors influencing ad
- Up regulated expression of fractalkine/CX3CL1 and CX3CR1 in patients with systemic sclerosis
- Standardised work-up programme for fever of unknown origin and contribution of magnetic resonance imaging for the diagnosis of hidden system
- Prevalence of anti-cyclic citrullinated peptide and anti-keratin antibodies in patients with primary Sj?gren’s syndrome
- Prevalence and determinants of one month hand pain and hand related disability in the elderly(Rotterdam study)
- Prevalence and predictors of fragility fractures in systemic lupus erythematosus
- When a DMARD fails, should patients switch to sulfasalazine or add sulfasalazine to continuing leflunomide?
- Validation and patient acceptance of a computer touch screen version of the WOMAC 3.1 osteoarthritis index
- Using patients’ and rheumatologists’ opinions to specify a short form of the WOMAC function subscale
- Association between baseline radiographic damage a
- Assessing competencies in rheumatology
- A multicentre, randomised, double blind, placebo c
- A good response to early DMARD treatment of patien
- Assessing competencies in rheumatology
- A multicentre, randomised, double blind, placebo controlled phase II study of subcutaneous interferon beta-1a in the treatment of patients w
- A good response to early DMARD treatment of patients with rheumatoid arthritis in the first year predicts remission during follow up
- Capability for daily activities in old people with rheumatoid arthritis: a population based study
- Association between baseline radiographic damage and improvement in physical function after treatment of patients with rheumatoid arthritis
- Contribution of polymorphisms in the apolipoprotein AI-CIII-AIV cluster to hyperlipidaemia in patients with gout
- Chondroprotective activity of N-acetylglucosamine in rabbits with experimental osteoarthritis
- Case number 32: Thiemann’s disease
- First line treatment of knee osteoarthritis in outpatients in France: adherence to the EULAR 2000 recommendations and factors influencing ad
- Evaluation of clinically relevant changes in patient reported outcomes in knee and hip osteoarthritis: the minimal clinically important impr
- Defining hip pain for population studies
- Low density of sympathetic nerve fibres and increased density of brain derived neurotrophic factor positive cells in RA synovium
- Is rheumatoid arthritis disappearing?
- Incidence and prevalence of complaints of the neck and upper extremity in general practice
- Prevalence and predictors of fragility fractures in systemic lupus erythematosus
- Patient centred outcomes in osteoarthritis
- Pain and joint mobility explain individual subdimensions of the health assessment questionnaire(HAQ) disability index in patients with rheu
- Prevalence of anti-cyclic citrullinated peptide and anti-keratin antibodies in patients with primary Sj?gren’s syndrome
- Prevalence and determinants of one month hand pain and hand related disability in the elderly(Rotterdam study)
- Using patients’ and rheumatologists’ opinions to specify a short form of the WOMAC function subscale
- Up regulated expression of fractalkine/CX3CL1 and CX3CR1 in patients with systemic sclerosis
- Standardised work-up programme for fever of unknown origin and contribution of magnetic resonance imaging for the diagnosis of hidden system
- When a DMARD fails, should patients switch to sulfasalazine or add sulfasalazine to continuing leflunomide?
- Validation and patient acceptance of a computer touch screen version of the WOMAC 3.1 osteoarthritis index